Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
argenx SE - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
ARGX
Nasdaq
2830
argenx.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for argenx SE
BofA Remains Bullish on Argenx (ARGX) With a Buy Rating and $804 PT
- Jun 30th, 2025 9:31 am
argenx Advances Clinical Development of ARGX-119 in Congenital Myasthenic Syndromes
- Jun 29th, 2025 11:00 pm
High Growth Tech Stocks In Europe To Watch June 2025
- Jun 26th, 2025 4:38 am
Exploring High Growth Tech Stocks In Europe June 2025
- Jun 25th, 2025 11:47 pm
High Growth Tech Stocks In Europe Featuring Ubisoft Entertainment And Two Others
- Jun 25th, 2025 4:38 am
Argenx Secures EC Approval for Subcutaneous VYVGART in CIDP Treatment
- Jun 24th, 2025 10:45 am
High Growth Tech Stocks To Watch In June 2025
- Jun 23rd, 2025 4:38 am
argenx Announces European Commission Approval of VYVGART Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy
- Jun 20th, 2025 11:00 am
High Growth Tech Stocks in Europe for June 2025
- Jun 18th, 2025 4:38 am
High Growth Tech Stocks In Europe To Watch
- Jun 17th, 2025 11:37 pm
argenx Presents New Efgartigimod Data at EULAR 2025 Highlighting Positive Phase 2 Proof-of-Concept Results in Myositis and Sjogren’s Disease
- Jun 10th, 2025 4:01 pm
High Growth Tech Stocks To Watch In Europe June 2025
- Jun 8th, 2025 11:41 pm
argenx SE (ARGX): A Bull Case Theory
- Jun 6th, 2025 2:30 pm
This IBD 50 Biotech's Got 'Rhythm' — And Flashes 3 Telltale Clues
- Jun 6th, 2025 2:00 pm
Nurix Therapeutics (NRIX) Moves 14.2% Higher: Will This Strength Last?
- Jun 3rd, 2025 7:09 am
argenx to Present at Goldman Sachs 46th Annual Global Healthcare Conference
- Jun 2nd, 2025 11:00 pm
Argenx added to Best Ideas List at Wedbush
- May 29th, 2025 7:00 am
argenx Announces Results of Annual General Meeting of Shareholders
- May 28th, 2025 2:01 pm
Argenx Set to See Further Growth Due to Vyvgart Momentum, Pipeline Expansion, Wedbush Says
- May 28th, 2025 9:05 am
argenx SE (ARGX): Among the Best Growth Stocks to Buy and Hold for the Long Term
- May 13th, 2025 8:16 pm
Scroll